AnalystBook Research · Company Intelligence

Angel Studios, Inc.

ANGXNYSE

Built from Angel Studios, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Angel Studios scaled revenue sharply in FY2025, but losses and leverage moved the other way.

The read at a glance✓ Audited against SEC data
  • BusinessCommunity-driven film and streaming studioNote
  • RevenueRevenue +233.2% to $321.6MOK
  • ProfitabilityNet loss worsened 93.1%Watch
  • MarginsGross margin +713 bpsOK
  • AccountingAltman-Z -8.409 distress; M/EQ safeWatch
  • Insiders2 purchases / 0 salesOK

Business

Angel Studios is a community-driven media company that develops, licenses, distributes, and monetizes films and series through the Angel App, theatrical releases, the Angel Guild, and related content-financing channels.

Where the revenue comes from

Fiscal 2025, as Angel Studios, Inc. reports it. History and quarterly detail are in the app.

  • Entertainment Licensed Content And Other Revenue$319.8M
  • Angel Guild Revenue$209.7M
  • Theatrical Release Revenue$77.0M
  • Content Licensing$24.5M
  • Merchandise Revenue$7.4M

Latest filings

  • 8-K · Company announcement2026-08-04
  • 10-Q · Quarterly report2026-08-04
  • 8-K · Company announcement2026-06-30
  • 8-K · Company announcement2026-06-18
  • 8-K · Company announcement2026-06-04
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Angel Studios, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.